Aditxt’s Acquisition Target Appili Therapeutics to Hold Special Shareholder Meeting on November 6, 2024, for Transaction Vote and Shareholder Approval

Aditxt’s acquisition target, Appili Therapeutics, has scheduled a special meeting for its shareholders on November 6, 2024. The purpose of this meeting is to discuss and vote on the proposed transaction, aiming to secure the necessary approval from Appili’s shareholders.